News Industry News TriReme Medical Reports Negative Late Lumen Loss At 24-Month Angiographic Follow-Up For Chocolate Heart™ Drug-Coated Coronary Balloon June 22, 2017
News Industry News Micell Technologies Highlights Data From Published Propensity Analysis of MiStent SES® and Market Standard Xience V® Coronary Stent February 24, 2016
News Industry News Micell Technologies Announces Completion of Enrollment in MiStent Randomized Trial Against Xience December 08, 2015
News Industry News First US Multi-center Study Finds Unprotected TAVR Procedures Produce New Brain Lesions in Nearly All Cases October 14, 2015
News Industry News EuroPCR Late-Breaking Clinical Trials: MiStent SES® Shows Clinical Superiority over Market-Leader Xience V in Propensity Analysis at One and Three Years Post-Treatment May 19, 2015